This was the stock's second consecutive day of gains.
The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...